Archiv
Dgap-Wpüg: Pflichtangebot

Offeror: Sanofi-Aventis; Target: Hoechst AG (Part 1 of 2)

Offeror: Sanofi-Aventis; Target: Hoechst AG (Part 1 of 2)

Wpüg-Mitteilung übermittelt durch die Dgap. Für den Inhalt der Mitteilung ist der Bieter verantwortlich. --------------------------------------------------------------------------------

Mandatory Publication pursuant to Sections 35 sub-sec. 1, zehn sub-sec. drei Securities Acquisition and Takeover Act (Wpüg) - Mandatory Offer (Part 1 of 2)

Offeror: Sanofi-Aventis 174 avenue de France 75013 Paris France Isin FR 0000120578 (WKN 920 657)

Target: Hoechst Aktiengesellschaft Industriepark Hoechst, Gebäude K 701 Brüningstraße 50 65926 Frankfurt am Main Germany Isin DE 0005758007 (WKN 575 800)

Other Companies directly affected by the Mandatory Offer: Aventis Cedex neun 67917 Strasbourg France Isin FR 0000130460 (WKN 925 700)

Sanofi-Aventis, a French stock corporation (société anonyme), hereby announces pursuant to Sections 35 sub-sec. 1, zehn sub-sec. drei Securities Acquisition and Take-over Act ("Wpüg") that by acquisition of the majority of the shares and voting rights of Aventis, a French stock corporation (société anonyme), on 20 August 2004, it gained indirect control in the meaning of Section 29 sub-sec. zwei Wpüg over Aventis' subsidiary Hoechst Aktiengesellschaft (Isin DE 0005758007, WKN 575 800).

Aventis holds a total of 548,451,852 of the 559,153,690 shares of Hoechst Aktiengesellschaft. This represents 98.09% of the registered share capital and the voting rights in Hoechst Aktiengesellschaft.

Following the acquisition of the majority participation in Aventis these voting rights in Hoechst Aktiengesellschaft are now attributed to Sanofi Aventis - pursuant to Section 30 sub-sec. 1 sentence 1 no. 1 Wpüg.

Through the acquisition of the majority participation in Aventis by Sanofi Aventis - on 20 August 2004, Total, a French stock corporation (société anonyme), zwei place de la Coupole, 92078 Paris La Défense Cedex, France, L'Oréal, a French stock corporation (société anonyme), 14 rue Royale, 75008 Paris, France, Téthys SAS, a French partnership limited by shares (société par actions simplifiée), 14 rue Royale, 75008 Paris, France, Ms Liliane Bettencourt, Mr André Bettencourt, Ms Françoise Bettencourt Meyers, Mr Jean- Pierre Meyers (each of these individual shareholders with address at 14 rue Royale, 75008 Paris, France), and Nestlé S.A., a Swiss stock corporation (société anonyme), avenue Nestlé 55 CH-1800 Vevey, Switzerland, also gained indirect control in the meaning of Section 29 sub-sec. zwei Wpüg over Hoechst Aktiengesellschaft. The 548,451,852 shares or 98.09% of the voting rights in Hoechst Aktiengesellschaft held by Aventis are also attributed to each of Total, L'Oréal, Téthys SAS, Ms Liliane Bettencourt, Mr André Bettencourt, Ms Françoise Bettencourt Meyers, Mr Jean-Pierre Meyers and Nestlé S.A. pursuant to Section 30 sub-sec. 1 sentence 1 no. 1 Wpüg.

Satisfying its obligations and the obligations of Total, L'Oréal, Téthys SAS, Ms Liliane Bettencourt, Mr André Bettencourt, Ms Françoise Bettencourt Meyers, Mr Jean-Pierre Meyers and Nestlé S.A. resulting from Section 35 Wpüg, Sanofi Aventis - will make a mandatory offer to the outside shareholders of Hoechst Aktiengesellschaft.

Subsequent to the approval by the German Federal Financial Supervisory Authority (Bundesanstalt für Finanzdienstleistungsaufsicht) the offer document for the mandatory offer will be published pursuant to Sections 35 sub-sec. 2, 14 sub-sec. drei sentence 1 no. 1 Wpüg on the Internet at http://www.sanofi-aventis.com and by public announcement of its free of charge availability.

Sanofi-Aventis reserves the right to purchase shares in Hoechst Aktiengesellschaft outside the mandatory offer as permitted under German law, provided such purchases shall not violate any applicable securities laws of any other jurisdiction. The offer document and announcements posted on the internet at http://www.sanofi-aventis.com will contain further information about any such purchases outside the mandatory offer.

This announcement is neither an offer to purchase nor a solicitation of an offer to sell securities of Hoechst Aktiengesellschaft. The offer will be contained in the offer document which will contain additional important information.

End part 1 of 2

Ende der Mitteilung (c)Dgap 23.08.2004 -------------------------------------------------------------------------------- Notiert: Sanofi-Aventis: Freiverkehr in Berlin-Bremen, Frankfurt, Hamburg, Hannover, München und Stuttgart; Hoechst AG: Amtlicher Markt in Frankfurt (General Standard); Freiverkehr in Berlin-Bremen, Düsseldorf, Hamburg, Hannover, München und Stuttgart; Aventis S.A.: Amtlicher Markt in Frankfurt (General Standard); Freiverkehr in Berlin-Bremen, Düsseldorf, Hamburg, Hannover, München, Stuttgart; Paris

Serviceangebote
Zur Startseite
-0%1%2%3%4%5%6%7%8%9%10%11%12%13%14%15%16%17%18%19%20%21%22%23%24%25%26%27%28%29%30%31%32%33%34%35%36%37%38%39%40%41%42%43%44%45%46%47%48%49%50%51%52%53%54%55%56%57%58%59%60%61%62%63%64%65%66%67%68%69%70%71%72%73%74%75%76%77%78%79%80%81%82%83%84%85%86%87%88%89%90%91%92%93%94%95%96%97%98%99%100%